Neutrophils have a short lifespan that is extended after exposure to granulocyte macrophage colony stimulating factor (GM-CSF) or lipopolysaccharide (LPS)^[@CR1]^. While the survival is regulated by BCL-2 family proteins^[@CR2]^, it is not known which pro-survival proteins are involved. GM-CSF stimulation in neutrophils upregulates A1, but *A1*-deficient mice showed no defects in this cell type^[@CR3]^. MCL-1 is critical for the survival of quiescent neutrophils^[@CR4],[@CR5]^, but it is not known whether the same holds true after activation. We hypothesized that A1 and MCL-1 have overlapping roles in the survival of activated neutrophils.

We generated mutant mice deficient for A1 and lacking one allele of *Mcl-1* (*Mcl-1*^*+/--*^*A1*^*--/--*^*). Mcl-1*^*+/--*^*A1*^*--/--*^ mice are grossly normal in the haematopoietic compartment, with only a small reduction in lymphocyte numbers, similar to *Mcl-1*^+/--^ mice^[@CR6]^ (Supplementary Fig. [1A](#MOESM1){ref-type="media"}). Loss of A1 did not cause a survival defect in GM-CSF-stimulated neutrophils. Here, we examined the survival of neutrophils activated with LPS plus GM-CSF from *A1*^*--/--*^, *Mcl-1*^*+/--*^, and *Mcl-1*^*+/--*^*A1*^*--/--*^ mice. Without stimulation, *Mcl-1*^*+/--*^ neutrophils had a significant survival disadvantage compared to their wild-type and *A1*^*--/--*^ counterparts and no further decrease in cell survival was observed in *Mcl-1*^*+/--*^*A1*^*--/--*^ neutrophils (Fig. [1a](#Fig1){ref-type="fig"}). Presumably, this increased apoptosis observed in *Mcl-1*^*+/--*^ neutrophils is due to the in vitro conditions, as we saw normal neutrophil numbers in vivo in *Mcl-1*^*+/--*^ or *Mcl-1*^*+/--*^*A1*^*--/--*^ mice (Supplementary Fig. [1B](#MOESM1){ref-type="media"}). After activation with LPS plus GM-CSF, the A1^−/−^ and *Mcl-1*^*+/--*^*A1*^*--/--*^ neutrophils exhibited significantly poorer survival, whilst *Mcl-1*^*+/--*^ neutrophils behaved similarly to wild-type cells (Fig. [1b](#Fig1){ref-type="fig"}). LPS treatment alone was ineffective at promoting a survival advantage and failed to induce neutrophil blasting or upregulate pro-survival MCL-1 expression (Supplementary Fig. [2A--C](#MOESM1){ref-type="media"}). GM-CSF treatment alone promoted survival, blasting, and MCL-1 upregulation in wild-type and *A1*^*--/--*^ cells^[@CR3]^. GM-CSF is known to induce expression of the TLR4 co-receptor CD14^[@CR7]^. We observed marked upregulation of CD14 on neutrophils after GM-CSF stimulation, and more so after treatment with GM-CSF plus LPS (Supplementary Fig. [2C](#MOESM1){ref-type="media"}). Hence, the survival defect of LPS plus GM-CSF-stimulated *A1*^−/−^ neutrophils could be due to a lack of increased A1 expression, contributing to the survival of activated neutrophils^[@CR8],[@CR9]^.Fig. 1Survival analysis of neutrophils from mice with the indicated genotypes cultured in **a** simple medium (no added cytokines), **b** after stimulation with 10 ng/mL GM-CSF plus 10 ng/mL LPS, **c** after treatment with Fc-FASL (0.6 ng/mL), and **d** after stimulation with LPS plus GM-CSF (10 ng/mL each) and Fc-FASL (0.6 ng/mL). **e** FASL-specific apoptosis when compared to survival of cells stimulated with LPS plus GM-CSF. Data are from five combined experiments (WT *n* = 9, *A1*^*--/--*^ *n* = 9, *Mcl-1*^*+/--*^ *n* = 6, *Mcl-1*^*+/--*^*A1*^*--/--*^ *n* = 7, *Bid*^*--/--*^ *n* = 7, and *Bid*^*--/--*^*A1*^*--/--*^ *n* = 7 mice). Statistical significance (\**P* \< 0.05, \*\**P* \< 0.01, \*\*\**P* \< 0.001, \*\*\*\**P* \< 0.0001) was determined using Student's *t*-test at each timepoint compared to WT (\*) or *A1*^*--/--*^ (†).

Neutrophils are highly sensitive to FAS-induced apoptosis^[@CR1]^, but this death is delayed when they are activated by LPS plus GM-CSF^[@CR1]^. We analyzed FASL-induced apoptosis with and without LPS plus GM-CSF stimulation in neutrophils from *A1* and *Mcl-1* mutant mice. Additionally, FASL-induced apoptosis in neutrophils is dependent on caspase-8-mediated activation of the pro-apoptotic BCL-2 family member BID (called tBID)^[@CR10]^, which A1 binds to with high affinity^[@CR11]^. We therefore also included *Bid*^*--/--*^ mice^[@CR12]^ as a control in our experiments and, furthermore, generated *Bid*^*--/--*^*A1*^*--/--*^ mice in order to examine whether any effects seen in the *A1*^*--/--*^ cells were dependent on A1--tBID interactions.

*Mcl-1*^*+/--*^ (and *Mcl-1*^*+/--*^*A1*^*--/--*^) neutrophils died quicker than wild-type cells after FASL treatment (Fig. [1c](#Fig1){ref-type="fig"}). FASL-induced apoptosis was greater than basal apoptosis in culture (Supplementary Fig. [3](#MOESM1){ref-type="media"}). *Bid*^*--/--*^ neutrophils were protected from FASL-induced apoptosis^[@CR10]^. LPS plus GM-CSF protected both wild-type and *Mcl-1*^*+/--*^ neutrophils against FASL-induced killing (Fig. [1d](#Fig1){ref-type="fig"}). In contrast, *A1*^*--/--*^ and *Mcl-1*^*+/--*^*A1*^*--/--*^ neutrophils exhibited significantly more apoptosis across all time points after treatment with FASL in LPS plus GM-CSF-activated neutrophils. Taking into account the increase in apoptosis after LPS plus GM-CSF stimulation in *A1*^*--/--*^ neutrophils. We observed a trend towards more FASL-specific apoptosis in the A1-deficient cells, although this only reached statistical significance at 72 h (Fig. [1e](#Fig1){ref-type="fig"}). The amount of FASL-specific apoptosis did not differ between *Bid*^*--/--*^ and *Bid*^*--/--*^ *A1*^*--/--*^ cells, indicating that the increased sensitivity of activated *A1*^*--/--*^ neutrophils to FASL killing is mediated by tBID. *Bid*^*--/--*^*A1*^*--/--*^ neutrophils displayed lower viability than their *Bid*^*--/--*^ counterparts, both after LPS plus GM-CSF stimulation (Supplementary Fig. [4](#MOESM1){ref-type="media"}) and with the combination of LPS, GM-CSF, and FASL (Fig. [1d](#Fig1){ref-type="fig"}), fitting with the role we showed for A1 in promoting cell survival after LPS plus GM-CSF stimulation alone.

Collectively, we demonstrate that upregulation of A1 after stimulation imparts a survival advantage in neutrophils, including FASL-induced apoptosis. However, A1's role is relatively small, and other factors must also regulate the survival of activated neutrophils. These results suggest a previously unrecognized role for A1 in promoting neutrophil survival in an inflammatory context.
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